Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double Blind, Placebo Controlled, Four Arm (Placebo, Tolterodine ER, Tamsulosin, and Tolterodine ER Plus Tamsulosin) Study To Evaluate The Clinical Efficacy And Safety Of Tolterodine ER 4 mg In Men Who Have Frequency and Urgency, With Or Without Urinary Urge Incontinence, With Or Without Bladder Outlet Obstruction
Brief Summary: The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).


Options:
A: Intervention Type: DRUG; Name: Tolterodine ER 4 mg QD; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Tamsulosin 0.4 mg QD; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Detrol LA; Assigned to Arm(s): N/A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to solifenacin, Drug: Placebo to tamsulosin | Arm Label: 6 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Arm Label: 9 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: Placebo to solifenacin; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo to tamsulosin; Assigned to Arm(s): Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg | Arm Label: TOCAS 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride OCAS 0.4 mg | Arm Label: FDC 0.4 mg/6 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Arm Label: FDC 0.4 mg/9 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg) | Intervention Type: DRUG; Name: Placebo tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, FDC 0.4 mg/9 mg, Placebo | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg; Assigned to Arm(s): FDC 0.4 mg/9 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg); Assigned to Arm(s): FDC 0.4 mg/6 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg); Assigned to Arm(s): FDC 0.4 mg/9 mg

Answer: A